Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US ```json { "@context": "https://schema.org", "@type": "Article", "headline": "Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US", "description": "Moderna shares rocketed $8.21 to $67.88 today, leading the broader market, after the company unveiled a new cell therapy program and built on a wave of regulatory momentum for its mRNA platform.", "image": [ "https://assets.simplefx.com/cms/f4698acb-f4af-47e2-af1b-6f9c7856194f.jpg" ], "datePublished": "2026-07-02T09:33:45.595Z", "dateModified": "2026-07-02T09:33:45.419Z", "author": { "@type": "Organization", "name": "SimpleFX", "url": "https://simplefx.com", "sameAs": [ "https://simplefx.com/social/x", "https://simplefx.com/social/linkedin", "https://github.com/SimpleFXcom/simplefx-api", "https://simplefx.com/social/facebook", "https://simplefx.com/social/youtube", "https://simplefx.com/social/telegram", "https://simplefx.com/social/tiktok", "https://www.trustpilot.com/review/simplefx.com" ] }, "publisher": { "@type": "Organization", "name": "SimpleFX", "logo": { "@type": "ImageObject", "url": "https://simplefx.com/assets/images/simplefx-logo.png", "width": 600, "height": 60 }, "url": "https://simplefx.com", "sameAs": [ "https://simplefx.com/social/x", "https://simplefx.com/social/linkedin", "https://github.com/SimpleFXcom/simplefx-api", "https://simplefx.com/social/facebook", "https://simplefx.com/social/youtube", "https://simplefx.com/social/telegram", "https://simplefx.com/social/tiktok", "https://www.trustpilot.com/review/simplefx.com" ] }, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://simplefx.com/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us" }, "articleSection": "交易教育", "keywords": "mrna.us, moderna, stocks, biotech, mrna, fda, cell-therapy, volatility", "inLanguage": "zh", "isAccessibleForFree": true, "wordCount": 574, "timeRequired": "PT3M" } ``` 78% 的散户投资者账户因与该 CFD 提供商进行 CFD 交易而遭遇现金损失。 CFD 是复杂的工具，由于杠杆作用，存在快速亏损的高风险。78% 的散户投资者账户在与该提供商交易 CFD 时亏损。您应该考虑您是否了解 CFD 的运作方式，以及您是否有能力承担亏损的高风险。 CFD 是复杂的工具，由于杠杆作用，存在快速亏损的高风险。78% 的散户投资者账户在与该提供商交易 CFD 时亏损。您应该考虑您是否了解 CFD 的运作方式，以及您是否有能力承担亏损的高风险。 [![SimpleFX logo](./assets/images/simplefx-logo.png?v=2)](zh/) 提供 [促销 新的 查看最新优惠活动](zh/promotions "查看最新优惠活动") [加密货币 在 SimpleFX 上查看比特币和山寨币](zh/offer/crypto "在 SimpleFX 上查看比特币和山寨币") [外汇 选择主要和次要货币对](zh/offer/forex "选择主要和次要货币对") [指数 参与全球指数](zh/offer/indices "参与全球指数") [商品 在能源和农业资产之间进行选择](zh/offer/commodities "在能源和农业资产之间进行选择") [金属 深挖高价值市场](zh/offer/metals "深挖高价值市场") [股票 探索美国、欧洲和亚洲的公司](zh/offer/equities "探索美国、欧洲和亚洲的公司") [Earn - Stake & Trade 通过质押和交易赚取额外收入](zh/earn-stake-trade "通过质押和交易赚取额外收入") [前往优惠](zh/offer) 交易信息 [我们的标志 交易多种金融资产](zh/instruments "交易多种金融资产") [支付方式 多种法定货币和加密货币选项](zh/payments "多种法定货币和加密货币选项") [SFX Coin 探索我们的代币提供的多种可能性](zh/sfx-simplefx-coin "探索我们的代币提供的多种可能性") [Bitcoin Lightning Network 加密货币交易达到新高度](zh/bitcoin-lightning-network "加密货币交易达到新高度") [交易新闻 每日市场分析和新闻更新](zh/trading-news "每日市场分析和新闻更新") [零费用 探索我们的免费功能](zh/zero-fees "探索我们的免费功能") 平台 [移动应用 随时随地进行交易](zh/mobile-app "随时随地进行交易") [桌面应用程序 充分利用 SimpleFX 的全部功能](zh/desktop-app "充分利用 SimpleFX 的全部功能") [Web 应用程序 利用尖端技术](zh/web-trader "利用尖端技术") [前往平台](zh/platforms) [![](./assets/header/timi-logo.png) 天米人工智能](zh/timi-ai-trade-mate) 公司 [关于 SimpleFX 查看我们品牌的基本信息](zh/about "查看我们品牌的基本信息") [网络安全意识 了解我们如何保护您的交易](zh/cybersecurity-awareness "了解我们如何保护您的交易") [连接业务 探索适合您业务的定制解决方案](zh/connect-for-business "探索适合您业务的定制解决方案") [帮助中心](zh/help-center) 热门搜索 [ BRENT](zh/instruments/BRENT)[ BTCUSD](zh/instruments/BTCUSD)[ DE40](zh/instruments/DE40)[ ETHUSD](zh/instruments/ETHUSD)[ EURUSD](zh/instruments/EURUSD)[ INTC.US](zh/instruments/INTC.US)[ MSTR.US](zh/instruments/MSTR.US)[ MU.US](zh/instruments/MU.US)[ NATGAS](zh/instruments/NATGAS)[ NVDA.US](zh/instruments/NVDA.US)[ OIL](zh/instruments/OIL)[ SPCX.US](zh/instruments/SPCX.US)[ TSLA.US](zh/instruments/TSLA.US)[ US100](zh/instruments/US100)[ US500](zh/instruments/US500)[ USDJPY](zh/instruments/USDJPY)[ XAGUSD](zh/instruments/XAGUSD)[ XAUUSD](zh/instruments/XAUUSD) [报名](https://app.simplefx.com/signup) [登录](https://app.simplefx.com/login) [报名](https://app.simplefx.com/signup) ZH [EN - English](/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [AR - العربية](/ar/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ES - Español](/es/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [FR - Français](/fr/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [HI - Hindi](/hi/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ID - Bahasa Indonesia](/id/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [KO - Korean](/ko/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [MY - Malay](/my/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [PT-BR - Português](/pt/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [RU - Русский](/ru/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [TH - ภาษาไทย](/th/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [TR - Türkçe](/tr/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [VI - Tiếng Việt](/vi/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ZH - 中文](/zh/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [登录](https://app.simplefx.com/login) [立即注册](https://app.simplefx.com/signup) 提供 [促销 新的 查看最新优惠活动](zh/promotions "查看最新优惠活动") [加密货币 在 SimpleFX 上查看比特币和山寨币](zh/offer/crypto "在 SimpleFX 上查看比特币和山寨币") [外汇 选择主要和次要货币对](zh/offer/forex "选择主要和次要货币对") [指数 参与全球指数](zh/offer/indices "参与全球指数") [商品 在能源和农业资产之间进行选择](zh/offer/commodities "在能源和农业资产之间进行选择") [金属 深挖高价值市场](zh/offer/metals "深挖高价值市场") [股票 探索美国、欧洲和亚洲的公司](zh/offer/equities "探索美国、欧洲和亚洲的公司") [Earn - Stake & Trade 通过质押和交易赚取额外收入](zh/earn-stake-trade "通过质押和交易赚取额外收入") [前往优惠](zh/offer) 交易信息 [我们的标志 交易多种金融资产](zh/instruments "交易多种金融资产") [支付方式 多种法定货币和加密货币选项](zh/payments "多种法定货币和加密货币选项") [SFX Coin 探索我们的代币提供的多种可能性](zh/sfx-simplefx-coin "探索我们的代币提供的多种可能性") [Bitcoin Lightning Network 加密货币交易达到新高度](zh/bitcoin-lightning-network "加密货币交易达到新高度") [交易新闻 每日市场分析和新闻更新](zh/trading-news "每日市场分析和新闻更新") [零费用 探索我们的免费功能](zh/zero-fees "探索我们的免费功能") 平台 [移动应用 随时随地进行交易](zh/mobile-app "随时随地进行交易") [桌面应用程序 充分利用 SimpleFX 的全部功能](zh/desktop-app "充分利用 SimpleFX 的全部功能") [Web 应用程序 利用尖端技术](zh/web-trader "利用尖端技术") [前往平台](zh/platforms) [![](./assets/header/timi-logo.png) 天米人工智能](zh/timi-ai-trade-mate) 公司 [关于 SimpleFX 查看我们品牌的基本信息](zh/about "查看我们品牌的基本信息") [网络安全意识 了解我们如何保护您的交易](zh/cybersecurity-awareness "了解我们如何保护您的交易") [连接业务 探索适合您业务的定制解决方案](zh/connect-for-business "探索适合您业务的定制解决方案") [帮助中心](zh/help-center) EN - English AR - العربية ES - Español FR - Français HI - Hindi ID - Bahasa Indonesia KO - Korean MY - Malay PT-BR - Português RU - Русский TH - ภาษาไทย TR - Türkçe VI - Tiếng Việt ZH - 中文 * [](zh/ "家") * [交易新闻](zh/trading-news) * Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US ============================================================================ Moderna shares rocketed $8.21 to $67.88 today, leading the broader market, after the company unveiled a new cell therapy program and built on a wave of regulatory momentum for its mRNA platform. Updated 16:05:11 26/06/2026 ![Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US](https://assets.simplefx.com/cms/medium_f4698acb-f4af-47e2-af1b-6f9c7856194f.jpg) MRNA.US Explodes Higher, Tops the Index --------------------------------------- Moderna shares surged 13.76% on June 26, 2026, adding $8.21 to reach $67.88 — a move that placed the stock at the front of the broader equity market. The single-session gain extends an already aggressive run: over the past month, the stock has climbed 44.43%, swinging between a low of $43.86 and a high of $69.23. The six-month picture is even more striking, with a gain of 119.68% off a low of $29.02. Over the trailing twelve months, MRNA.US has advanced 151.54%, with a 52-week low of $22.24 and a 52-week high of $67.58. Cell Therapy Reveal and FDA Backing Drive the Breakout ------------------------------------------------------ Analysis suggests today's move was driven by two converging catalysts. First, Moderna unveiled a new cell therapy program at its Science Day event, with the company highlighting the expanding potential of its mRNA platform across multiple modalities. According to finance.yahoo.com, the Science Day provided a broad overview of research and early development programs, including validation of a T-cell engager modality with mRNA-2808 in multiple myeloma, supporting rapid advancement of a second T-cell engager, mRNA-2151, in ovarian cancer. The company also introduced an in vivo CAR-T modality with mRNA-6007 moving into early development for autoimmune diseases. Market drivers include the company's stated strategic direction toward becoming a diversified, multi-modality biotechnology company managing multiple commercial franchises. Second, investor confidence was reinforced by recent unanimous FDA advisory panel support for mFlusiva, Moderna's mRNA-based flu shot. Finance.yahoo.com reported that the FDA's Vaccines and Related Biological Products Advisory Committee unanimously backed mFlusiva for adults 50 and older, after phase 3 data showed it to be about 27% more effective than a standard flu vaccine. Analysis suggests this endorsement positions the mRNA platform for a potential second major commercial use beyond COVID-19. Fool.com noted the stock has already doubled this year and is still racing toward a major catalyst. Historical Highs in Sight as Momentum Builds -------------------------------------------- The one-month high of $69.23 represents the nearest overhead reference point visible in the historical data. On the downside, the one-month low of $43.86 and the six-month low of $29.02 mark the range from which the current rally has been constructed. The 151.54% gain over the trailing twelve months, off a low of $22.24, underscores the scale of the recovery. The pipeline of upcoming regulatory and clinical milestones — including the potential commercial trajectory of mFlusiva and the early-stage cell therapy programs — represents the next set of fundamental inflection points that analysis suggests the market will be watching closely. ### Risk Factors * High volatility after a 13.76% single-session move increases risk of sharp mean-reversion. * Clinical-stage programs including mRNA-2808, mRNA-2151, and mRNA-6007 carry inherent development and regulatory failure risk. * FDA advisory panel support for mFlusiva does not guarantee full regulatory approval; final agency decisions remain pending. * The stock has gained 119.68% over six months, raising the risk that near-term expectations are already priced in. * Concentration risk remains if the mRNA platform fails to achieve commercial diversification beyond COVID-19 as anticipated. * Broader market or sector-wide sentiment shifts could amplify downside given the elevated valuation implied by the 151.54% one-year gain. This article is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Investors should conduct their own due diligence before making any investment decisions. Price data retrieved as of 2026-06-26T16:01:05.693Z and may not reflect real-time market conditions. SimpleFX Markets Desk — real-time price movement analysis for active traders #### 准备开始投资了吗？ 注册 SimpleFX [立即注册](https://app.simplefx.com/signup) 或注册 × 简单开户。 开始投资的简单方法。 无费用，无最低存款 输入你的电子邮箱 我接受[使用条款](https://simplefx.com/legal-documents)和[隐私政策](https://simplefx.com/privacy-policy/)。 立即开设账户 ![发现 SimpleFX](/assets/images/new-sfx-app-webtrader-mobile-v2@2x.png) ![SimpleFX](assets/images/simplefx-logo-white.png) 在 - 找到我们 [](/social/facebook)[](/social/linkedin)[](/social/youtube)[](/social/tiktok)[](/social/telegram) 加入我们的社区 [](/social/x)[](/social/discord) 下载SimpleFX [](https://simplefx.com/get-app/ios) 扫描此二维码 下载应用程序。 ![](https://api.simplefx.com/mobile-store/qr/ios) [](https://simplefx.com/get-app/android) 扫描此二维码 下载应用程序。 ![](https://api.simplefx.com/mobile-store/qr/android) [提供](zh/offer) 提供 [加密货币](zh/offer/crypto) [外汇](zh/offer/forex) [指数](zh/offer/indices) [商品](zh/offer/commodities) [股票](zh/offer/equities) [金属](zh/offer/metals) [Earn - Stake & Trade](zh/earn-stake-trade) [促销](zh/promotions) [TiMi - AI 交易伙伴](zh/timi-ai-trade-mate) [前往优惠](zh/offer) [平台](zh/platforms) 平台 [移动应用](zh/mobile-app) [桌面应用程序](zh/desktop-app) [Web 应用程序](zh/web-trader) [前往平台](zh/platforms) 交易信息 [我们的标志](zh/instruments) [支付方式](zh/payments) [SFX - SimpleFX Coin](zh/sfx-simplefx-coin) [Bitcoin Lightning Network](zh/bitcoin-lightning-network) [零费用](zh/zero-fees) [API](https://github.com/SimpleFXcom/simplefx-api) [交易新闻](zh/trading-news) 支持 [帮助中心](zh/help-center) [经常问的问题](zh/faq) [地位](zh/status) [货币计算器](zh/currency-calculator) 学院 [教育](zh/education) [交易术语表](zh/trading-glossary) 公司 [关于我们](zh/about) [网络安全意识](zh/cybersecurity-awareness) [连接业务](zh/connect-for-business) [品牌资产](zh/brand-assets) 附属机构 [成为一个合伙人（参与者](zh/affiliate) [Unilink](zh/unilink) 隐私和监管 [合法文件](zh/legal-documents) [滚下](zh/rollover) [隐私政策](zh/privacy-policy) [Cookie 政策](https://simplefx.com/resources/SimpleFX_CookiesPolicy.pdf) **SimpleFX Group**由以下实体组成： **8TECH LTD**经毛里求斯金融服务委员会授权并受其监管，许可证号为 GB23201604。办公地址：毛里求斯埃比尼银银大厦 Cybercity，银行街 18 号底层。8TECH LTD 不提供任何法定货币兑换服务和加密货币兑换服务。8TECH LTD 不支持加密货币交易账户或加密货币存款。 **8TECH ZA (PTY) LTD 是**一家加密资产服务提供商和 FSP，持有南非金融部门行为监管局 (FSCA) 授权的 53073 号许可证，办公地址：4 Haven Lane Malvern Queensburgh Durban Kwa-Zulu Natal 4093，南非。8TECH ZA (PTY) LTD 提供加密货币存款，并支持基于 FSCA 53073 号许可证的加密货币交易账户，并提供加密资产子类别。 **8TECH PA LLC**已获得库纳德瓦尔甘迪国际服务管理局 (KUNAISA) 的许可，持有外汇交易许可证（许可证号：FX0032026）和虚拟资产服务提供商 (VASP) 许可证（许可证号：V0042026），公司编号为 0004-IBC-2026，注册地址为巴拿马共和国库纳德瓦尔甘迪地区努拉瓦拉莫尔蒂镇库奈萨大厦中央大街。8TECH PA LLC 是 SimpleFX 网站（免费交易和投资平台）的所有者。 **SimpleFX 集团**未获得任何欧盟机构、欧洲经济区国家主管部门或英国的授权。SimpleFX 服务不受欧盟和英国监管框架的约束。您不受投资者赔偿基金的保障。 本网站上的信息并不构成，也不应被解释或理解为从事任何投资或交易活动的诱导或招揽，也不旨在向欧盟、欧洲经济区或英国公民营销或推广 SimpleFX 服务。 **SimpleFX Group**不向美国或任何分发或使用违反当地法律或法规的国家的公民和居民提供服务。 **风险警告** 外汇、虚拟资产或其他保证金场外产品的保证金交易具有高风险，可能并不适合所有人。我们建议您根据个人情况仔细考虑交易是否适合您。 CFD 是复杂的工具，由于杠杆作用，存在快速亏损的高风险。78% 的散户投资者账户在与该提供商交易 CFD 时亏损。您应该考虑您是否了解 CFD 的运作方式，以及您是否有能力承担亏损的高风险。 任何利润都可能需要缴税，您应该就您的税务状况寻求独立建议。 2026 SimpleFX版权所有。 [ 写信给我们。 我们每周 5 天、每天 24 小时响应。 ](https://app.simplefx.com/login?action=open-livechat)